The influence of heparin on the reaction between thrombin and plasminogen activator inhibitor-l (PAI-1) has been examined. With a 50-fold excess of PAI-1, the rate constant for the inhibition of thrombin was 458 mol/L"s", which increased to 5,000 mol/L"s" in the presence of 25 pg/mL unfractionated heparin or heparin with low affinity for antithrombin. The effect of low affinity heparin was then examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, using close to equimolar concentrations of reactants. Thrombin and PAI-1 formed a stable stoichiometric complex in the absence of heparin, which did not dissociate after the addition of 25 pg/mL low-affinity heparin. In contrast, when low-affinity heparin was added at the beginning of the reaction, there was an initial increase in PAI-1-thrombin complex formation, but this was rapidly followed EPAFUN IS A HIGHLY sulfated glycosaminoglycan consisting of alternating glucosamine and iduronic or glucuronic residues. Within this basic structure, considerable heterogeneity exists with regard to side-chains and extent of sulfation. Heparin exerts its anticoagulant effect through the activation of the serpin antithrombin lIl.'-3 A specific pentasaccharide sequence: present in about 30% of the heparin chains,* mediates the high-affinity binding to antithrombin 111. Binding to heparin induces a conformational change at the reactive center PI arginine residue of antithrombin.6 This conformational change is responsible for the majority of the enhanced inhibition of factor Xa. In contrast, the majority of the activation towards thrombin results from a template or surface approximation mechanism, whereby sequestration of fluid phase antithrombin and thrombin onto the heparin increases the local concentration and, hence, the rate of react i~n .~.~ In addition to its direct anticoagulant action via the antithrombin mechanism, it has been proposed by some investigators that heparin can also stimulate the fibrinolytic systern."," Indications that heparin has effects on the fibrinolytic system have come from a number of in V~V O '~"~ and animal16,17 studies, but such studies are sometimes difficult to interpret because of the potential superposition of by substantial proteolytic cleavage of unreacted PAL1 and of the thrombin-PAL1 complex. The idea that the relative concentrations of thrombin and PAI-1, and the presence of low affinity heparin, could influence the products of the reaction was examined in detail. Quantitative zymographic analysis of tissue plasminogen activator and PAL1 activities and chromogenic substrate assay of thrombin activity showed that low-affinity heparin stimulated the inactivation of PAI-1 by an equimolar amount of thrombin, but caused only a minimal stimulation of thrombin inhibition. It is concluded that low-affinity heparin stimulates thrombin inhibition when PAL1 is in excess, but, unexpectedly, that low-affinity heparin enhances PAL1 inactivation when thrombin is equimolar to PAI-1.
by substantial proteolytic cleavage of unreacted PAL1 and of the thrombin-PAL1 complex. The idea that the relative concentrations of thrombin and PAI-1, and the presence of low affinity heparin, could influence the products of the reaction was examined in detail. Quantitative zymographic analysis of tissue plasminogen activator and PAL1 activities and chromogenic substrate assay of thrombin activity showed that low-affinity heparin stimulated the inactivation of PAI-1 by an equimolar amount of thrombin, but caused only a minimal stimulation of thrombin inhibition. It is concluded that low-affinity heparin stimulates thrombin inhibition when PAL1 is in excess, but, unexpectedly, that low-affinity heparin enhances PAL1 inactivation when thrombin is equimolar to PAI-1. bleeding caused by the anticoagulant action of heparin on any profibrinolytic action.ls A possible mechanism for the profibrinolytic action of heparin is activation of the contact system-dependent fibrinolytic pathway,lg but studies with plasma have yielded ambiguous results. 20321 The possibility that heparin might have a fibrinolytic effect through modulating plasminogen activator inhibitor-l (PAI-1) activity was suggested by the in vivo study of Agnelli et al." PAI-1, a proteinase inhibitor of the serpin family, is the primary inhibitor of tissue plasminogen activator (t-PA),22.23 and as such plays a critical role in the regulation of fibrinolysis. The importance of maintaining the correct levels of PAL1 is demonstrated by the association of disease states with both ele~ated'~.'~ and decreased26 PAL1 levels. Further evidence for an involvement of PAI-l in heparin-induced fibrinolysis has come from studies showing that heparin enhances the rate of thrombin inhibition by PAI-l.27.28 Vitronectin also enhances the rate of thrombin inhibition by PAI-lz8.''; however, thrombin has also been shown to inactivate PAI-1 associated with vitronectin in the extracellular matrix.30 In the present study, we provide evidence that heparin with low affinity for antithrombin stimulates PAI-1 neutralization by thrombin.
to cyanogen bromide-activated Sepharose-4B (Pharmacia) in the presence of acetylated heparin."
Kinetic srudies. PAI-I was standardized by titration against t-PA using the chromogenic substrate S-2288 at 1.47 mmoVL in 50 mmol/L Tris-HCI, pH 7.4, 127 mmol/L NaCi, at 37°C assuming a reaction stoichiometry of 1. The recombinant PAI-1 assayed by this method was at least 90% active when removed from storage at -70°C. However, once thawed, the PAI-I reverted to the latent form.'3 Although latent PAI-I could be activated by treatment with denaturants, the reactivated form was not used in any of the experiments described here.
For determination of the second-order rate constant of the inhibition of thrombin by PAI-I, thrombin (110 nmolk) was incubated at 23°C with PAI-I (5.2 pmol/L) in the presence or absence of heparin in a volume of 40 pL, in phosphate-buffered saline (PBS) containing 1 mg/mL bovine serum albumin (BSA). At various times, 5-pL aliquots were assayed for residual enzymatic activity, using 330 pL of S-2238 (0.15 mmol/L) in 50 m m o K Tris-HCI, pH 7.4, 127 mmoVL NaCI, at 37°C. The absorbance change at 405 nm was continuously recorded using a Gilford 260 spectrophotometer (CibaComing, Oberlin, OH). Second-order reaction rate constants were derived from pseudo-first-order plots. '4 Electrophoretic studies. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), nonreduced, was performed using a Bio-Rad Mini gel system by the method of Laem~nli.~' The acrylamide concentration in stacking gels was 4% and the concentration present in the separating gels was 12%. Gels were stained with Coomassie blue R-250. Westem blotting was performed using a BioRad mini-blot system. After transfer, the nitrocellulose membrane (0.45 pm; Micron Separations Inc, Westboro, MA) was blocked in 2% BSA (fraction V; Sigma). PAI-1 was detected with goat anti-HT l080 PAL1 antibody (American Diagnostica, Greenwich, CT) at 1/2,000 dilution, and shown with rabbit antigoat IgGhorseradish peroxidase conjugate (Fisher Biotech, Pittsburgh, PA). The blot was developed with 0.6 mg/mL 4-chloro-l-naphthol, 0.012% HzOz in 50 mmol/L Tris-HC1, pH 7.5, 80 mmolk NaCl, 2 mmol/L CaCIz, 20% methanol.
Zymogruphic analysis. Samples containing PAI-l or t-PA were incubated as described in the text and in the legends to Figs 6 and 7, followed by assay on either zymograms or reverse zymograms as described below. For the zymograms, fibrin-agarose underlays36 (12 mL, poured onto a 7.2 X 10.1 cm glass plate) were prepared with 0.75% (wt/vol) Agarose A (Phmacia), 2.5 mg/mL bovine fibrinogen, 17 ng/mL human a-thrombin, and 0.05% Triton X-100, in 50 mmol/L sodium barbital, pH 7.8, 93 mmol/L sodium chloride, 1.7 mmol/L calcium chloride, and 0.7 m o l / L magnesium chloride. Five-microliter samples containing t-PA were loaded into wells in the fibrin-agarose gel. Wells were made with a well puncher. After overnight incubation in a humid chamber, underlays were washed with distilled water, dried in an oven at SOT, and stained with Coomassie blue R-250. The area of the lysis ring was measured and a linear standard curve of lysis area versus log of t-PA concentration was constructed. This method could be used to quantitate t-PA from I pg/5 pL (3.6 pmol/L) down to IO pg/5 pL (36 pmol/L).
Reverse zymograms3' were prepared in the same way as regular zymograms except for the inclusion of 8.3 ng/mL urokinase in the agarose underlay. Quantification of PAI-l concentration by reverse zymography was performed by aliquoting 5 pL of the sample to test into a hole punched in the gel, in a manner analogous to the quantitative zymography described above. The gel was incubated for 18 hours in a humid chamber, followed by washing, drying, and staining. A standard curve for PAI-I was constructed by measuring the area of the zone protected from lysis, and plotting the area of the protected zone against the log of the PAI-I concentration. With this method there is a linear relationship between these parameters for PAL1 concentrations ranging from 0.5 pg/5 pL (2.4 FmoVL) to 5 ng/5 pL (24 nmol/L). Control experiments showed that the presence of heparin or thrombin did not interfere with the activity of t-PA or PAI-I on the zymograms or reverse zymograms, respectively.
RESULTS
Effect of heparin fractions on the inhibition of thrombin by PAI-l: chromogenic substrate studies.
Under pseudofirst-order conditions, with a 50-fold excess of PAI-l over thrombin, the second-order rate constant for the inhibition of thrombin by PAI-1 was 458 mol/L"s-l. The effect of various heparin species on this reaction was determined as shown in Fig 1. A maximum rate constant of 5,000 mol/ L"s-l was obtained with unfractionated heparin concentrations between 15 and 45 pglmL (Fig 1, top left) . This rate enhancement decreased at higher concentrations of heparin. An essentially identical result was seen with low-affinity heparin (Fig 1, top right) . High-affinity heparin showed the same dose dependency as unfractionated heparin, but a slightly higher maximum rate constant of 6,000 mol/L-Is" was obtained (Fig 1, bottom left) . In contrast, the maximal inhibition rate constant with 18 pg/mL of low molecular weight heparin was only 1,700 mol/L-'s" at ( Fig 1, bottom  right) .
Effect of low-afinity heparin on the reaction of thrombin and PAI-I: SDS-PAGE studies. The experiments shown in Figs 2 through 5 were performed using various PA1:thrombin molar ratios. The effect of the reactant concentration and the presence of heparin on the outcome of a 15-minute reaction between thrombin and PAI-1 is shown in Fig 2. The relative molar amounts of PAI-1 to thrombin were 5:l in lanes 3 and 6, 1:l in lanes 4 and 7, and 1:5 in lanes 5 and 8 ( Fig  2) . With PAI-1 in excess, the reaction between PAI-1 (M, 42,000) and thrombin (M, 37,000) led to formation of a bimolecular PAI-l-thrombin complex (Mr 73,000), with no significant effect of low-affinity heparin on the reaction products (Fig 2, lanes 3 and 6) . When thrombin was in excess, there was significant degradation of PAI-1 and of the PAI-1 -thrombin complex (Fig 2, lane 5 ). In the presence of lowaffinity heparin, the degradation became even more profound, with minimal complex remaining undegraded (Fig 2,  lane 8 ). In addition, at equimolar concentrations of thrombin and PAI-1 (Fig 2, lanes 4 and 7) , significant PAI-l -thrombin complex formation was seen in the absence of low-affinity heparin (Fig 2, lane 4) , whereas thrombin remained essentially uncomplexed in the presence of low-affinity heparin (Fig 2, lane 7) .
The time course of the reaction between PAL1 and thrombin at equimolar concentrations is shown in Fig 3. PAL1 and thrombin were incubated in the absence (lanes 3 through 6) or the presence (lanes 7 through 10) of low-affinity heparin (25 pg/mL). By comparing lanes 3 and 7 (l-minute time point), it can be seen that low-affinity heparin enhanced the initial rate of complex formation, as would be expected from [LMWHI ug/ml 1 (M, 41,000) was formed with a molecular weight slightly less than the native form (M, 42,000).
The mechanism of cleavage of the PAL1 -thrombin complex was investigated in Fig 4. The complex was formed in a 30-minute preincubation with a limiting amount of thrombin (Fig 4, lane 3) , and then incubated for a further 15 minutes with either buffer (Fig 4, lane 4) , low-affinity heparin (Fig 4, lane S ) , thrombin (Fig 4, lane 6) , or thrombin and low-affinity heparin (Fig 4, lane 7) . Addition of low-affinity Effect of reactant concentration and low-affinity heparin on the reaction of PAI-l and thrombin. Ten-microliter samples were incubated with PBS at 23°C for l 5 minutes, followed by mixing with sample buffer containing 1 mmol/L PMSF, run on 12% SDS-PAGE, and stained with Coomassie blue R-250. Lane 1, 1.8 p g PAI-1; lane 2, 1.7 p g thrombin; lanes 3 and 6,9 p g PAI-1 and 1.7 p g thrombin; lanes 4 and 7, 1.8 p g PAL1 and 1.7 p g thrombin; lanes 5 and 8, 1.8 p g PAI-l and 8.5 p g thrombin. Samples were incubated in the absence (lanes 3, 4, and 5) or presence (lanes 6, 7, and 8) of low-affinity heparin at 25 pg/ mL. Right margin numbers are M, X 10-.3.
Fig 1.
Effect of heparin fractions on the inhibition of thrombin by PAI-l. The second-order rate constant (mol/L"s") for the inhibition of thrombin by PAI-1 was determined under pseudo-first-order conditions in the presence of different heparin species as indicated. UFH, unfractionated heparin; LAH, low-affinity heparin; HAH, high-affinity heparin; LMWH, low molecular weight heparin.
heparin alone did not cause spontaneous dissociation of the PAI-I -thrombin complex, and addition of extra thrombin caused only a minimal amount of complex degradation. Addition of both caused considerable degradation of the bimolecular PAL 1 -thrombin complex (Fig 4. lane 7) . The band seen at M, 31.000 in the SDS gels was shown by Western blotting to contain PAI-I antigen (data not shown). Low molecular weight heparin did not cause cleavage of the PAIl-thrombin complex (data not shown). Thus, heparin acts 
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as a template not only for the initial encounter of thrombin and PAI-I , but also for the interaction of thrombin with the PAI-I-thrombin complex. To confirm the stability of the PAL I -thrombin complex, preformed complex was incubated with the thrombin inhibitor PPACK for up to 3 hours in the absence (Fig S, lanes 4 through 6) or presence of 25 pg/mL low-affinity heparin (Fig S. lanes 7 through 9) . No degradation or dissociation occurred, indicating the irreversible nature of the complex and confirming its stability in the presence of heparin.
Effect of low-qflnity heparin on the thromhh-mediclted inactivation sf PAI-I: zymographic studies. The ability of unfractionated and low-affinity heparin to stimulate the inactivation of PAI-I by thrombin was tested using zymographic assays for both PAI-I and t-PA activity. PAI-I was assayed (Fig 6A) , or 190 nmol/L PAI-I with 216 nmol/L thrombin ( Fig 6B) in the presence or absence of 25 pg/mL of unfractionated or low-affinity heparin are illustrated. In both sets of experiments. the loss of PAI-I activity caused by thrombin was enhanced by both unfractionated heparin and low-affinity heparin. Although an identical molar ratio of PAI-I to thrombin was used in the two sets of experiments, the incubations at higher reactant concentrations (Fig 6B) showed greater inactivation of PAI-I , indicating that the reaction followed second-order kinetics. The inactivation of PAI-I by thrombin and heparin was confirmed by assaying the ability of thrombin-treated PAI-I to inhibit t-PA (Fig 7) . In Fig 7A, 5 and 8) . or 3 hours (lanes 6 and 9). Right margin numbers are M, x 10 '.
with or without 25 pg/mL unfractionated or low-affinity heparin, followed by incubation with 29 nmol/L t-PA and determination of the remaining t-PA activity by quantitative zymography. Figure 7B shows a similar experiment using 105 nmol/L PAL I . Control experiments indicated that PAI-1 alone completely inhibited t-PA (Fig 7A and B, lane l ) . Addition of thrombin to the preincubation mixtures caused partial inactivation of PAI-I, with about 2 0 8 of the original t-PA being detectable (Fig 7A and B. lane 2) . This effect was enhanced by unfractionated or low-affinity heparin ( Fig  7A and B, lanes 3 and 4) . For example, the proportion oft-PA detectable by zymography after preincubation of 105 nmol/L PAI-1 and 2 16 nmol/L thrombin increased from 14% in the absence of heparin (Fig 7B. lane 2) Inactivation of PAL1 by thrombin and heparin determined by t-PA activity on quantitative zymography. PAL1 was preincubated for 15 minutes at 23°C as described below, followed by the addition of t-PA to 29 nmollL and incubation for a further 15 minutes before loading onto the zymogram for assay of residual t-PA activity. 
DISCUSSION
PAI-1 has affinity for heparin through lysine residues analogous to those in the heparin binding site of another serpin, antithr~mbin,~' and binding to heparin endows PAI-l with thrombin inhibitory activity." Gebbink et a139 showed that stimulation of thrombin inhibition by PAL1 was specific to heparin, with other glycosaminoglycans having much less stimulatory effect. These studies, h o w e~e r ,~' *~~,~~ were concerned primarily with the inhibition of thrombin by PAL1 and the stimulation of this reaction by heparin, but they did not examine the effect of thrombin and heparin on PAI-1 activity. The objective of the study reported here was to assess the influence of thrombin and various heparin forms on PAI-1. Our results indicate that unfractionated heparin and heparin with low affinity for antithrombin increase the inhibition of thrombin by PAL1 when the serpin is in molar excess over the serine proteinase. However, when thrombin and PAI-1 are present at equimolar concentrations or when there is a molar excess of thrombin, these two forms of heparin considerably stimulate PAL1 cleavage and inactivation; importantly, thrombin is only weakly inhibited during these reactions.
The second-order rate constant for the inhibition of thrombin by PAI-1 in the absence of heparin was 458 moVL"s" (Fig 1) . In the presence of unfractionated heparin, the maximum second-order rate constant was 5,000 moVL"s-l, occuring between 15 and 45 pg/mL of heparin. Heparin can be fractionated into forms with low and high affinity for antithrombin. The results with these two forms were essentially identical to the results obtained with the unfractionated material, indicating that the pentasaccharide responsible for the high-affinity binding to antithrombin was not necessary for PAI-1 binding. Moreover, the smaller stimulation observed with low molecular weight heparin (maximum rate constant, 1,700 moVL-ls"), and the shape of the dose response curves, confirmed that heparin was acting through the template (or surface approximation) mechanism. The fact that low-affinity heparin had the same ability to stimulate the reaction as unfractionated heparin suggested that lowaffinity heparin could be a useful agent in distinguishing the anticoagulant effect of heparin from its profibrinolytic action. Therefore, a detailed investigation of the action of lowaffinity heparin on the reaction between PAI-1 and thrombin was performed.
The inhibition of thrombin by PAL1 was studied under pseudo-first-order conditions, with a 50-fold molar excess of PAI-l over thrombin. However, to assess its biologic relevance, the interaction of PAI-1 and thrombin should be examined at reactant concentrations likely to occur in vivo. PAL1 concentration in normal plasma is less than 20 ng/ mL (0.4 nm0l/L),4~,~' although localized concentrations of PAI-1 could be much higher as a result of PAI-1 release from activated platelets or PAL1 association with the extracellular m a~x . 4 Z . 4 3 For example, the PAL1 concentration in pathologic human thrombi can be over 1 pg/g of wet thrombus.M. As far as the concentration of thrombin is concerned, the following considerations have to be taken into account. Prothrombin concentration in normal plasma is 100 p g / d (1. presence of 25 pg/mL of unfractionated heparin (Fig 7B,  lane 3) . Effect of heparin on the inhibition of thrombin amidolytic activity by PAI-I: studies with enzyme excess. The data reported in the preceeding paragraph indicate that unfractionated or low-affinity heparin can enhance PAI-l inactivation by thrombin, as determined by both direct and indirect zymographic assays of PAI-1 activity (Figs 6 and 7) . Additional experiments were undertaken to assess how thrombin amidolytic activity was influenced under the reaction conditions used for these zymographic studies. The kinetics of inhibition of thrombin (108 nmoVL) by PAI-1 (95 nmoVL) with or without heparin are shown in Fig 8. In the absence of heparin, thrombin activity was reduced by about 20% at 20 minutes (Fig 8, squares) . In the presence of 25 pg/mL unfractionated heparin or low affinity heparin, a 25% to 40% reduction of thrombin amidolytic activity was observed within 1 to 2 minutes, followed by an additional 10% to 15% reduction at 20 minutes (Fig 8, circles and triangles) . For comparison, greater than 85% inhibition of thrombin was observed when thrombin (108 nmol/L) was incubated for 1 minute with antithrombin I11 (95 nmoVL) and 25 pg/ mL unfractionated heparin. Similarly, greater than 85% inhibition of t-PA was observed when t-PA (108 nmol/L) was incubated for 1 minute with PAL1 (95 nmoVL).
For personal use only. on October 26, 2017. by guest www.bloodjournal.org From PmoVL). Thus, 1% activation of prothrombin would generate a thrombin concentration of l pg/mL, (14 nmol/L). Locally, thrombin concentration could be higher, but a significant amount will be continually sequestered by antithrombin (and other serpins such as heparin cofactor 11), as well as by ligands such as thromborn~dulin~~ and heparan sulfate.46 Because of these and other reasons, such as the location and extent of vascular injury, amount of platelet activation, and rate of flow (and therefore removal of reactants), it is difficult to predict with certainty the in vivo concentrations of PAI-1 and thrombin at the site of tissue damage and thrombus formation. Although a large excess of PAI-l over thrombin could be present in vivo, it is also possible that the PAI-1 concentration will be closer to that of thrombin. Therefore, with this reasoning in mind, the effect of low-affinity heparin on the interaction of thrombin and PAI-1 was further characterized by a series of polyacrylamide gels (Figs 2 through  5) . Using approximately equimolar concentrations of PAI-l and thrombin, it can be seen that, although low-affinity heparin stimulated the initial rate of complex formation, it also potentiated the degradation of complex by thrombin. With thrombin in excess over PAI-1, minimal thrombin-PAI-1 complex was formed. In this situation, neutralization of PAI-1 by thrombin is likely to be the relevant process. This process seems to occur through formation of PAI-1 -thrombin complex, proteolytic cleavage of PAI-1 at the reactive site bond, and cleavage of the serpin at other sites. Moreover, the observation that active serine proteinase and inactivated serpin are detectable among the products of the reaction between thrombin and PAI-1 is consistent with several reports indicating that serpins are suicide substrates for serine p r o t e i n a s e~.~~.~~ To determine whether the reactions observed by SDS-PAGE were also taking place in a nondenatured system, PAI-1 activity was measured both directly by reverse zymography (Fig 6) and indirectly by its ability to inhibit t-PA, with the t-PA assayed by conventional zymography (Fig 7) . Both methods confirmed that thrombin neutralizes PAI-1 activity and that unfractionated and low-affinity heparin stimulate this reaction. In addition, when thrombin inhibition was studied with close to equimolar reactant concentrations (Fig 8) , thrombin inhibition was minimal in the absence of heparin. Addition of unfractionated or low-affinity heparin to the incubation led to less than 40% inhibition of thrombin. Importantly, the same incubation conditions led to an 85% loss of PAI-1 activity.
There is no evidence to suggest that inhibition of thrombin by PAI-1 has any physiologic role per se, given the systemic concentrations of the major thrombin inhibitors (antithrombin 111, 2.6 pmol/L; heparin cofactor 11, 0.14 pmol/L), compared with that of PAI-1 (0.4 nmol/L). Rather, in view of the data presented here, it is more likely that the significance of the reaction between thrombin and PAI-1 lies in the inactivation of PAI-1. Moreover, our observation that PAI-1 inactivation by thrombin is augmented by the presence of unfractionated or low-affinity heparin indicate that these two heparin forms have the potential to enhance fibrinolysis. The high rates of reocclusion seen after thrombolytic therapy are believed to result from the release of clot bound thr~mbin,~" de novo thrombin generati~n,~' and platelet with PAI-l r e l e a~e .~~, '~ In addition, the resistance of thrombi to spontaneous lysis increases with increasing PAL 1 in those thrombi.& Administration of heparin with thrombolytic agents is standard p r a c t i~e .~~-~' Although part of the potentiation of thrombolysis seen with heparin administrations8 may be caused by activation of antithrombin, the inactivation of PAI-1 by the thrombin-dependent mechanism described herein may also be an important factor. Evidence that reduction in PAI-1 activity is beneficial to thrombolytic therapy is given by a study showing that a monoclonal anti-PAI-1 antibody enhanced thrombolysis and reduced thrombus extension in a rabbit
There is a growing body of evidence that elevated PAL1 is a risk factor for thromboembolic disease, as a result of decreased fibrinolytic activity." The data reported here, showing that low-affinity heparin can enhance the inactivation of PAI-1, suggest that lowaffinity heparin might have a therapeutic role in such cases. In addition, low-affinity heparin has the potential of becoming an important adjunctive agent for thrombolytic therapy, in particular if its administration is not associated with the bleeding complications seen with conventional heparin.
